Carfilzomib, Elotuzumab and Dexamethasone for Relapsed or Refractory Myeloma Patients
Silvennoinen, Raija Helena, Nahi, Hareth, Anttila, Pekka, Koskenvesa, Perttu, Lievonen, Juha, Marttila, Anu, Varmavuo, Ville, Sikiö, Anu, Nurmi, Marita, Säily, Marjaana, Partanen, Anu, Sankelo, Marja, Luoma, Sini, Mäntymaa, Pentti, Ilveskero, Sorella, Rode Eshoj, Henrik, Nielsen, Lene Kongsgaard, Jantunen, Esa, Heckman, Caroline A
Published in BLOOD (05.11.2020)
Published in BLOOD (05.11.2020)
Get full text
Journal Article
Conference Proceeding
A Phase 2 Study of Carfilzomib Plus Elotuzumab Plus Dexamethasone for Myeloma Patients Relapsed after 1-3 Prior Treatment Lines
Silvennoinen, Raija Helena, Tsallos, Dimitrios, Nahi, Hareth, Anttila, Pekka, Koskenvesa, Perttu, Lievonen, Juha, Räsänen, Anu, Varmavuo, Ville, Sikiö, Anu, Nurmi, Marita, Säily, Marjaana, Partanen, Anu, Sankelo, Marja, Luoma, Sini, Ilveskero, Sorella, Pelliniemi, Tarja-Terttu, Jantunen, Esa, Majumder, Muntasir M, Eldfors, Samuli, Leppä, Maija, Heckman, Caroline A
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
A phase 2 study of carfilzomib plus elotuzumab plus dexamethasone for myeloma patients relapsed after 1-3 prior treatment lines
Silvennoinen, Raija, Majumder, Muntasir Mamun, Tsallos, Dimitrios, Nahi, Hareth, Anttila, Pekka, Partanen, Anu, Luoma, Sini, Sikiö, Anu, Nurmi, Marita, Varmavuo, Ville, Säily, Marjaana, Sankelo, Marja, Jantunen, Esa, Pelliniemi, Tarja-Terttu, Ilveskero, Sorella, Eshoj, Henrik Rode, Nielsen, Lene Kongsgaard, Eldfors, Samuli, Leppä, Aino-Maija, Heckman, Caroline
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (01.10.2019)
Published in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (01.10.2019)
Get full text
Journal Article
Conference Proceeding